Home › Funds › PFM Health Sciences, LP › LLY
PFM Health Sciences, LP position in LLY
ELI LILLY CO · Health Care
PFM Health Sciences, LP reported holding 39,258 shares of LLY (ELI LILLY CO) in its Q2 2026 13F filing — a position valued at US$47.1M, representing 4.12% of its reported portfolio and ranking #3 among its reported holdings. PFM Health Sciences, LP has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's LLY position evolved
PFM Health Sciences, LP first disclosed a stake in LLY in Q3 2023 at 298,643 shares (US$160.4M). The position peaked in Q2 2024 at 298,643 shares, worth US$270.4M. Across 12 filings, PFM Health Sciences, LP increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 39,258 shares valued at US$47.1M — a reduction of -26,504 shares quarter over quarter.. Notable position changes include a 70% trim in Q4 2025 (shares fell 14% over the following quarter), a 40% trim in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 298.64K | $160.41M | New |
| Q4 2023 | 298.64K | $174.08M | Hold |
| Q1 2024 | 298.64K | $232.33M | Hold |
| Q2 2024 | 298.64K | $270.39M | Hold |
| Q3 2024 | 298.64K | $264.58M | Hold |
| Q4 2024 | 298.64K | $230.55M | Hold |
| Q1 2025 | 273.78K | $226.12M | Reduce |
| Q2 2025 | 268.02K | $208.93M | Reduce |
| Q3 2025 | 225.14K | $171.78M | Reduce |
| Q4 2025 | 68.29K | $73.39M | Reduce |
| Q1 2026 | 65.76K | $60.49M | Reduce |
| Q2 2026 | 39.26K | $47.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LLY and 13F data
LLY (ELI LILLY CO) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LLY
- LILLY ENDOWMENT INC 90.07M sh · $104.21B · Q3 2026
- Vanguard Group 81.97M sh · $88.09B · Q4 2025
- BlackRock Inc 67.54M sh · $81.01B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 53.53M sh · $64.20B · Q2 2026
- PNC Financial Services 51.32M sh · $61.56B · Q2 2026
- Fidelity Management & Research (FMR) 28.46M sh · $34.14B · Q2 2026
- STATE STREET CORP 35.61M sh · $32.75B · Q1 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 20.86M sh · $25.02B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 20.31M sh · $24.28B · Q2 2026
- Geode Capital Management 20.31M sh · $24.28B · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held LLY?
PFM Health Sciences, LP has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in LLY?
As of Q2 2026, PFM Health Sciences, LP holds 39.26K shares of LLY (ELI LILLY CO), valued at $47.09M, representing 4.12% of its reported portfolio and ranking #3.
Has PFM Health Sciences, LP been buying or selling LLY?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in LLY. The position peaked in Q2 2024 at 298.64K shares.
Which other funds hold LLY?
Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.